Navigation Links
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Date:6/30/2009

git royalties on sales of products resulting from the collaboration.

"This collaboration serves as an excellent fit with our recombinant Factor VIII and Factor IX hemophilia products and provides us with an opportunity to expand Wyeth's hemophilia franchise," says Mikael Dolsten, President, Wyeth Research. "We have been impressed by the caliber of Catalyst's therapeutic protein engineering skills used in the Factor VIIa program and the lead candidate CB 813. We look forward to a highly productive collaboration."

"We are thrilled to join forces with Wyeth, a biopharmaceutical company at the forefront of both hemophilia treatment and the development and commercialization of biologic therapies," says Nassim Usman, Ph.D., Chief Executive Officer of Catalyst Biosciences. "This collaboration highlights the value Catalyst has created in our Factor VIIa portfolio of products. Revenues generated from research collaborations such as this one allow us to continually expand and support existing discovery efforts around bleeding disorder product candidates and the engineering of new Alterase therapeutic products."

About Catalyst Biosciences

Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of engineered proteases to target proteins underlying disease. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates that cleave a wide variety of disease targets, either by improving existing protease drugs or by creating new protease drugs, known as Alterase(TM) therapeutics. Initially, Catalyst is focusing its product development efforts on drug candidates for hemophilia, age-related macular degeneration and inflammation. To date, Catalyst has established multiple discovery research and product development agreements with Wyeth Pharmaceuticals and Centocor Research & Development, Inc. Catalyst is priva
'/>"/>

SOURCE Catalyst Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Suzanne Bakken, PhD, RN, FAAN, ... Institute of Medicine (IOM) of the National Academies. , She is the Alumni ... Nursing. A member of the Institute of Medicine since 2006, Bakken also currently ...
(Date:9/1/2015)... ... September 01, 2015 , ... Ogawa’s new massage chairs ... robots more effective and humanlike than ever before. With the goal of bringing wellness ... and the Ogawa Active SuperTrac. , As in its name, the Ogawa ...
(Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring fast, easy-to-understand ... the most convenient time for everyone involved. These occasions highlight the value of ... Translation Services has real people available to handle any translation assignment at ...
(Date:9/1/2015)... CINCINNATI, OHIO (PRWEB) , ... September 01, 2015 , ... ... US today at JourneyLite of Cincinnati. In the last month the FDA has ... ReShape Duo ™. These procedures represent the first incisionless, reversible, weight loss ...
(Date:9/1/2015)... TN (PRWEB) , ... September 01, 2015 , ... ... users to send information about new patients directly from Practice Perfect to FOTO ... duplicate data entry. , Steven Presement, President of Practice Perfect, ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... ... proprietary Figure-Eight™ Technology, new CirQlation™ Elite offers vibration massage and ability to convert into ... ... U.S. market leader of innovative massage chairs , Perfect Chair® Recliners and other ...
... Patients taking Lexapro had better thinking, learning and memory ... MONDAY, Feb. 1 (HealthDay News) -- Taking antidepressants after ... improve mental functioning, a new study suggests. , Little ... abilities, such as thinking, learning and memory, after initial ...
... , , ... vaccine development , SILVER SPRING, Md. , ... (FDA) today announced a collaboration with PATH to advance development ... Streptococcus pneumoniae (pneumococcus), especially pneumonia. , (Logo: ...
... , Oral ... CHICAGO , Feb. 1 February is ... of the important role early dental care plays in children,s overall ... take action early to insure the health of their children,s teeth ...
... innate interest in the new and different may help ... published by the American Psychological Association. In controlled experiments, ... got cocaine. Novelty could help break the ... many addicts with novelty-craving, risk-taking personalities, the authors said. ...
... ... (CFO) of Santen Inc., as its 2010 president. , ... San Francisco (Vocus) -- Ophthalmic Women Leaders (OWL) ... president., , , , ,Prior to her appointment as president, Gleeson previously served as ...
Cached Medicine News:Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 2Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 3Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 4Health News:Antidepressants After Stroke May Boost Mental Ability 2Health News:Antidepressants After Stroke May Boost Mental Ability 3Health News:FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries 2Health News:FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries 3Health News:February Is National Children's Dental Health Month 2Health News:February Is National Children's Dental Health Month 3Health News:February Is National Children's Dental Health Month 4Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 2Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 3Health News:Ophthalmic Women Leaders (OWL) Names Pamela Gleeson, CFO Of Santen Inc., as 2010 President 2
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... PLEASANTON, Calif. , Aug. 31, 2015  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... assembly and distribution of advanced therapeutic solutions for ... today the final results of the below-the-knee ("BTK") ... Registry ("BAR") which were presented on August 15, ...
(Date:8/31/2015)... Aug. 31, 2015   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell ... cryopreservation freeze media and a related ... for smart shippers ("BioLife" or the ... an advanced biopharmaceutical company focused on developing and ...
Breaking Medicine Technology:Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... Va., Feb. 9, 2011 With generous funding ... Palliative Care Association are partnering to improve pain ... hospitals in The Gambia, Kenya, and Malawi. ... they each have well-established national palliative care organizations, ...
... Design Trends: Technological Advances in Implantable Devices, a UBM Canon Medical Device ... Industry ( MD+DI ) , ... , and OrthoTec , is now on-demand ... 1,092, with an attendance of 50% during the live event held on ...
Cached Medicine Technology:FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: